Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2023-03-20 Annual Report
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 22nd fiscal year (2022), submitted to the Financial Supervisory Service and Korea Exchange. It contains comprehensive financial data, company overview, management discussion, and governance details. In the context of Korean regulatory filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report. It is not an announcement or a summary, but the full statutory annual filing. FY 2022
2023-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company Peptron (피플바이오) on March 17, 2023. It contains the auditor's opinion, consolidated and separate financial statements, and key financial metrics such as capital impairment ratios and operating losses. While it provides financial data, it is a regulatory filing specifically announcing the receipt and submission of the audit report to the exchange, which falls under the 'Audit Report / Information' category as it provides the audit results and financial summary required by regulatory standards. FY 2022
2023-03-17 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by PeopleBio. It outlines the date, location, and agenda items (such as approval of financial statements, election of directors, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the PSI category.
2023-03-13 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for PeopleBio. It contains the meeting agenda, details on voting procedures (including electronic voting), and financial statements (balance sheet, income statement, etc.) as part of the management's reference materials for the upcoming AGM. According to the filing definitions, documents containing materials shared for the Annual General Meeting are classified as AGM-R.
2023-03-13 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the agenda, information about the solicitors, and the company's financial statements (balance sheet, income statement, etc.) as required by law for shareholder review prior to the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (PeopleBio) regarding a significant change in financial results (revenue/profit structure change of 30% or more). This is a standard disclosure requirement for listed companies in Korea (DART system) to announce preliminary financial results before the final audit is completed. Since it provides key financial highlights and performance metrics rather than a full annual report or a simple announcement of a report's availability, it falls under the Earnings Release (ER) category. FY 2022
2023-02-08 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.